TARS NASDAQ · Healthcare · FY 2025-12-31
Tarsus Pharmaceuticals, Inc.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○
Low · 1/4
Price
59.040 USD
Market cap
2.51B USD
P / B
7.32
P / E
—
EPS
-1.590
DPS / yield
— (0.0%)
NAV / share
7.897
Graham number
—
Z'' score
3.02
Piotroski F
5 / 9
Beneish M
-1.59
ROIC vs WACC
-22.0%
vs 7.8%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.